Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoran Gatalica

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Clinical Breast Cancer|January 14, 2022
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the BreastSemir Vranic, Zoran Gatalica
Familial Cancer|June 15, 2007
Pathology of the hereditary colorectal carcinomaZoran Gatalica, Emina Torlakovic
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2002
Loss of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasiaEduardo Eyzaguirre, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences|June 28, 2021
Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkersSemir Vranic, Zoran Gatalica
Cancer Letters|January 24, 2006
COX-2 expression in pseudomyxoma peritoneiZoran Gatalica, Brian Loggie
Croatian Medical Journal|April 30, 2005
Syk tyrosine kinase expression during multistep mammary carcinogenesisZoran Gatalica, Zhanyong Bing
Acta Medica Academica|June 2, 2021
The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief ReviewSemir Vranic, Zoran Gatalica
Biomolecules & Biomedicine|August 14, 2022
PD-L1 testing by immunohistochemistry in immuno-oncologySemir Vranic, Zoran Gatalica
Biomolecules & Biomedicine|April 24, 2024
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapySemir Vranic, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences|December 28, 2016
Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkersSemir Vranic, Rebecca Feldman, Zoran Gatalica
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Clinical Breast Cancer|January 14, 2022
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the BreastSemir Vranic, Zoran Gatalica
Familial Cancer|June 15, 2007
Pathology of the hereditary colorectal carcinomaZoran Gatalica, Emina Torlakovic
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2002
Loss of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasiaEduardo Eyzaguirre, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences|June 28, 2021
Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkersSemir Vranic, Zoran Gatalica
Cancer Letters|January 24, 2006
COX-2 expression in pseudomyxoma peritoneiZoran Gatalica, Brian Loggie
Croatian Medical Journal|April 30, 2005
Syk tyrosine kinase expression during multistep mammary carcinogenesisZoran Gatalica, Zhanyong Bing
Acta Medica Academica|June 2, 2021
The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief ReviewSemir Vranic, Zoran Gatalica
Biomolecules & Biomedicine|August 14, 2022
PD-L1 testing by immunohistochemistry in immuno-oncologySemir Vranic, Zoran Gatalica
Biomolecules & Biomedicine|April 24, 2024
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapySemir Vranic, Zoran Gatalica
Bosnian Journal of Basic Medical Sciences|December 28, 2016
Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkersSemir Vranic, Rebecca Feldman, Zoran Gatalica
Pageof 21